Public consultation on proposed amendments to the Poisons Standard - ACMS, ACCS & Joint ACMS-ACCS, MARCH 2023

Closed 3 Feb 2023

Opened 5 Jan 2023

Contact

Medicines Scheduling

1800 020 653

medicines.scheduling@health.gov.au

Feedback updated 13 Jul 2023

We asked

From 5 January 2023 to 3 February 2023, we sought submissions from the public on scheduling proposals referred to the March 2023 meetings of the Advisory Committees on Medicines and Chemicals Scheduling. Respondents were given the choice to indicate their support or opposition to the proposed amendments using survey buttons, with or without a written response.

You said

We received a total of 10 submissions in response to the pre-meeting public notice for March 2023. The breakdown of the responses has been provided below:

CELECOXIB: A total of 6 responses were received for celecoxib 4 in full support, 1 in partial support and 1 in opposition of the proposal. Of these responses, 5 provided a written response, 4 in support and 1 in partial support.

BROMOXYNIL: A total of 3 responses were received for bromoxynil, 2 in full support and 1 in opposition of the proposal. Of these, the 2 responses in support of the proposal contained a written response.  

DIOXANE: A total of 6 responses were received for dioxane, 2 in full support, 1 in partial support and 3 in opposition of the proposal. Of these, 1 submission in support, 1 submission in partial support and 2 submissions opposed contained a written component.

AZELAIC ACID: A total of 4 responses were received for azelaic acid, 3 in full support and 1 in opposition of the proposal. Of these submissions, 2 responses in support of the proposal contained a written component.

We did

The Delegates considered all submissions prior to making an interim decision on these proposals. The interim decisions on the proposed amendments to the Poisons Standard were published on 12 July 2023.

Published responses

View submitted responses where consent has been given to publish the response.

Overview

Scheduling amendments referred to expert advisory committee

This consultation is for applications and delegate initiated proposals to amend the Poisons Standard. The scheduling amendments and any submissions received will be considered at the March 2023 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).

The closing date for this consultation is close of business 3 February 2023. All submissions received by the deadline will be considered by the delegate before they make an interim decision.

CONTENT WARNING
The documents below contain information regarding self-poisoning that some people may find distressing.

The Department of Health and Aged Care acknowledges the devastating effects associated with acts of self-harm on individuals, their families, friends and communities.

If you or someone you know needs additional support, please contact any of the below crisis support helplines:

Support services and information sources

Adult
• Lifeline: 13 11 14
• Suicide Call Back Service: 1300 659 467
• Beyond Blue: 1800 512 348
• MensLine Australia: 1300 789 978

Youth
• Kids Helpline (5-25 years): 1800 551 800
• Headspace: 1800 650 890
• ReachOut

The proposals under consultation are detailed in the public notice of March 2023. 

Substances for which public comment is sought:

SUBSTANCE 1: CELECOXIB
SUBSTANCE 2: AZELAIC ACID
SUBSTANCE 3A: BROMOXYNIL
SUBSTANCE 3B: DIOXANE
 

What happens next

All public submissions will be published on the TGA website at Public submissions on scheduling matters, unless marked confidential or indicated otherwise in the submission information (see Privacy and your Personal information).

Public submissions are an important part of the process for amending the Poison Standard, and are published on the TGA website using the consultation hub.  Submissions by the public may not reflect the views of the Department of Health and Aged Care or TGA.  Published submissions should not be taken as being endorsed by the Department or TGA.

Following consideration of public submissions received before the closing date and advice from the expert advisory committee/s, decisions on the proposed amendments are anticipated to be published as interim decisions on the TGA website: Scheduling delegate's interim decisions & invitations for further comment in June 2023.

Audiences

  • Aboriginal and Torres Strait Islander People
  • Seniors
  • Men
  • Women
  • Carers and guardians
  • Families
  • Parents
  • Young people
  • Academics
  • Non-government organisations
  • State government agencies
  • Commonwealth agencies
  • Local governments
  • Health professionals
  • Health workforce
  • General public
  • Community groups
  • Businesses
  • Contracted Service Providers
  • Aged care service providers
  • Aged care workforce
  • Aged care professionals
  • BPRU staff
  • Graduates
  • Online and Publications staff
  • Secretariat
  • PCCD
  • Health staff
  • HPRG (TGA) Staff
  • Prescription medicines
  • Complementary medicines
  • Over-the-counter medicines
  • Medical Devices & IVDs
  • Biologicals
  • Other

Interests

  • Policy Development